相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of mRNA-1273 and BNT162b2 Vaccines on Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Death During the Delta-Predominant Period
Lindsey Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
Nicole Wolter et al.
LANCET (2022)
Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud
Andrew Hill et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Katherine A. Twohig et al.
LANCET INFECTIOUS DISEASES (2022)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19 A Systematic Review and Meta-analysis
Perrine Janiaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Sophie Juul et al.
PLOS ONE (2021)
Platform Trials - Beware the Noncomparable Control Group
Lori E. Dodd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (vol 12, 2349, 2021)
Cathrine Axfors et al.
NATURE COMMUNICATIONS (2021)
Use of electronic health records to support a public health response to the COVID-19 pandemic in the United States: a perspective from 15 academic medical centers
Subha Madhavan et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial
Douglas Yee et al.
JAMA ONCOLOGY (2020)
A potentially effective treatment for COVID-19: A systematic review and meta-analysis of convalescent plasma therapy in treating severe infectious disease
Mengyao Sun et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Sophie Juul et al.
PLOS MEDICINE (2020)
Risk for In-Hospital Complications Associated with COVID-19 and Influenza - Veterans Health Administration, United States, October 1, 2018-May 31, 2020
Jordan Cates et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Racial, Ethnic, and Geographic Disparities in Novel Coronavirus (SARS-CoV-2) Test Positivity in North Carolina
Nicholas A Turner et al.
Open Forum Infectious Diseases (2020)
A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
CANCER CELL (2020)
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
Alejandro Piscoya et al.
PLOS ONE (2020)
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates
Donald A. Berry et al.
PLOS ONE (2020)
A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Ramy Mohamed Ghazy et al.
SCIENTIFIC REPORTS (2020)
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis
Shirley Sze et al.
ECLINICALMEDICINE (2020)
Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples
L. A. Renfro et al.
ANNALS OF ONCOLOGY (2017)
The life cycles of six multi-center adaptive clinical trials focused on neurological emergencies developed for the Advancing Regulatory Science initiative of the National Institutes of Health and US Food and Drug Administration: Case studies from the Adaptive Designs Accelerating Promising Treatments Into Trials Project
Timothy C. Guetterman et al.
SAGE OPEN MEDICINE (2017)
Adaptive Randomization of Neratinib in Early Breast Cancer
J. W. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
I-SPY 2-Toward More Rapid Progress in Breast Cancer Treatment
Lisa A. Carey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
Roy S. Herbst et al.
CLINICAL CANCER RESEARCH (2015)
Bayesian Designs and the Control of Frequentist Characteristics: A Practical Solution
Steffen Ventz et al.
BIOMETRICS (2015)
Adaptive Clinical Trial Design
Shein-Chung Chow
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
Matthew R. Sydes et al.
TRIALS (2012)
The ClinicalTrials.gov Results Database - Update and Key Issues
Deborah A. Zarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
ViEWS-Towards a national early warning score for detecting adult inpatient deterioration
David R. Prytherch et al.
RESUSCITATION (2010)
分享论文
